ProductLife Group in Australia
Regulatory Affairs & Safety Expertise in Australia, connected to a global Life Sciences network.
Who we are
Following the acquisition of Commercial Eyes in 2023, ProductLife Group strengthened its strategic presence in the JAPAC region and expanded its global service capabilities. With more than two decades of experience supporting regulated healthcare products in Australia and New Zealand, Commercial Eyes brings deep regional expertise to the Group. This integration enhances PLG’s ability to support pharmaceutical and MedTech companies across the full product lifecycle, from development through to market and patient access, on a truly global scale.
Our Focus
At PLG Australia, we focus on Regulatory Affairs and Safety & Vigilance services, enabling Life Sciences companies to successfully navigate the Australian market.
As of 2025, the office’s initial areas of expertise include:
- Patient safety strategy and consulting services
- QPPV & Local Safety Officer services
- Pharmacovigilance case processing and local filing/reporting
- Medical & technical writing
- Regulatory strategy, submissions and lifecycle maintenance
- PMDA consultation and access services
Services
Safety & Vigilance:
- Pharmacovigilance case processing & local reporting
- Signal detection & literature surveillance
- Medical technical writing
- Patient safety strategy, QPPV & LSO services
Regulatory Affairs:
- Regulatory & development strategy tailored to Australian regulations
- J-NDA submissions and new product registrations
- PMDA consulting and access services
- Clinical trial approvals
- Lifecycle maintenance & compliance
Our role in Japac
With a growing number of offices across the JAPAC region, ProductLife Group provides regulatory and safety services to life sciences companies operating in both mature markets including Japan, Australia, New Zealand, South Korea, and Singapore, and emerging markets across Southeast Asia.
Commercial Eyes partners with life sciences organisations to turn innovation into meaningful healthcare outcomes. Operating across Australia and New Zealand, the team delivers patient-focused regulatory, market access and commercialisation support to help safe and effective therapies reach patients.
Contact us
Melbourne Head Office
Level 5, 447 Collins Street, Melbourne VIC 3000
Sydney Office
Level 21/60 Margaret St, Sydney NSW 2000